Search Results

There are 6412 results for: content related to: Inhibition of MDMA -induced increase in cortisol does not prevent acute impairment of verbal memory

  1. You have free access to this content
    MDMA ‘ecstasy’ increases cerebral cortical perfusion determined by bolus-tracking arterial spin labelling (btASL) MRI

    British Journal of Pharmacology

    Volume 169, Issue 5, July 2013, Pages: 974–987, J Rouine, O L Gobbo, M Campbell, V Gigliucci, I Ogden, K McHugh Smith, P Duffy, B Behan, D Byrne, M E Kelly, C W Blau, C M Kerskens and A Harkin

    Version of Record online : 12 JUN 2013, DOI: 10.1111/bph.12178

  2. You have free access to this content
    The preclinical pharmacology of mephedrone; not just MDMA by another name

    British Journal of Pharmacology

    Volume 171, Issue 9, May 2014, Pages: 2251–2268, A R Green, M V King, S E Shortall and K C F Fone

    Version of Record online : 11 APR 2014, DOI: 10.1111/bph.12628

  3. You have free access to this content
    Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats

    British Journal of Pharmacology

    Volume 171, Issue 1, January 2014, Pages: 83–91, Charles W Schindler, Eric B Thorndike, Bruce E Blough, Srihari R Tella, Steven R Goldberg and Michael H Baumann

    Version of Record online : 10 DEC 2013, DOI: 10.1111/bph.12423

  4. You have free access to this content
    Sex-dependent long-term effects of adolescent exposure to THC and/or MDMA on neuroinflammation and serotoninergic and cannabinoid systems in rats

    British Journal of Pharmacology

    Volume 171, Issue 6, March 2014, Pages: 1435–1447, Ana Belen Lopez-Rodriguez, Alvaro Llorente-Berzal, Luis M Garcia-Segura and Maria-Paz Viveros

    Version of Record online : 4 MAR 2014, DOI: 10.1111/bph.12519

  5. You have free access to this content
    Mechanisms mediating the ability of caffeine to influence MDMA (‘Ecstasy’)-induced hyperthermia in rats

    British Journal of Pharmacology

    Volume 160, Issue 4, June 2010, Pages: 860–877, N Vanattou-Saïfoudine, R McNamara and A Harkin

    Version of Record online : 24 MAY 2010, DOI: 10.1111/j.1476-5381.2010.00660.x

  6. MDMA and Other “Club Drugs”

    Standard Article

    Handbook of Contemporary Neuropharmacology

    M. Isabel Colado, Esther O'Shea and A. Richard Green

    Published Online : 2 MAR 2007, DOI: 10.1002/9780470101001.hcn039

  7. You have free access to this content
    Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone-induced hypothermia

    British Journal of Pharmacology

    Volume 168, Issue 4, February 2013, Pages: 966–977, SE Shortall, AR Green, KM Swift, KCF Fone and MV King

    Version of Record online : 24 JAN 2013, DOI: 10.1111/j.1476-5381.2012.02236.x

  8. You have free access to this content
    The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives

    British Journal of Pharmacology

    Volume 160, Issue 5, July 2010, Pages: 1029–1044, JR Docherty and AR Green

    Version of Record online : 3 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00722.x

  9. You have free access to this content
    Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility

    Journal of Neurochemistry

    Volume 124, Issue 1, January 2013, Pages: 69–78, Lucia Frau, Nicola Simola, Antonio Plumitallo and Micaela Morelli

    Version of Record online : 15 NOV 2012, DOI: 10.1111/jnc.12060

  10. You have free access to this content
    Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): a stressor on the immune system

    Immunology

    Volume 111, Issue 4, March 2004, Pages: 357–367, Thomas J. Connor

    Version of Record online : 30 MAR 2004, DOI: 10.1111/j.0019-2805.2004.01847.x

  11. You have free access to this content
    Methylenedioxymethamphetamine (‘Ecstasy’)-induced immunosuppression: a cause for concern?

    British Journal of Pharmacology

    Volume 161, Issue 1, September 2010, Pages: 17–32, Noreen T Boyle and Thomas J Connor

    Version of Record online : 25 MAY 2010, DOI: 10.1111/j.1476-5381.2010.00899.x

  12. Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases

    Human Psychopharmacology: Clinical and Experimental

    Volume 27, Issue 4, July 2012, Pages: 352–363, Cecilie L. Licht, Maria Christoffersen, Mads Okholm, Lærke Damgaard, Anders Fink-Jensen, Gitte M. Knudsen and David Erritzoe

    Version of Record online : 14 JUN 2012, DOI: 10.1002/hup.2234

  13. You have free access to this content
    Pharmacological profile of novel psychoactive benzofurans

    British Journal of Pharmacology

    Volume 172, Issue 13, July 2015, Pages: 3412–3425, Anna Rickli, Simone Kopf, Marius C Hoener and Matthias E Liechti

    Version of Record online : 24 APR 2015, DOI: 10.1111/bph.13128

  14. You have free access to this content
    Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research

    Human Psychopharmacology: Clinical and Experimental

    Volume 28, Issue 4, July 2013, Pages: 289–307, Andrew C. Parrott

    Version of Record online : 23 JUL 2013, DOI: 10.1002/hup.2318

  15. Adolescent pre-exposure to ethanol and 3,4-methylenedioxymethylamphetamine (MDMA) increases conditioned rewarding effects of MDMA and drug-induced reinstatement

    Addiction Biology

    Volume 17, Issue 3, May 2012, Pages: 588–600, Bruno Ribeiro Do Couto, Manuel Daza-Losada, Marta Rodríguez-Arias, Roser Nadal, Consuelo Guerri, Teresa Summavielle, Jose Miñarro and Maria A. Aguilar

    Version of Record online : 13 OCT 2011, DOI: 10.1111/j.1369-1600.2011.00382.x

  16. 3,4-methylenedioxymethamphetamine increases excitability in the dentate gyrus: role of 5HT2A receptor-induced PGE2 signaling

    Journal of Neurochemistry

    Volume 136, Issue 5, March 2016, Pages: 1074–1084, Stuart A. Collins, Courtney Huff, Nicolas Chiaia, Gary A. Gudelsky and Bryan K. Yamamoto

    Version of Record online : 19 JAN 2016, DOI: 10.1111/jnc.13493

  17. The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 2, August 2011, Pages: 246–255, CM Hysek, LD Simmler, M Ineichen, E Grouzmann, MC Hoener, R Brenneisen, J Huwyler and ME Liechti

    Version of Record online : 15 JUN 2011, DOI: 10.1038/clpt.2011.78

  18. Persistent cerebrovascular effects of MDMA and acute responses to the drug

    European Journal of Neuroscience

    Volume 24, Issue 2, July 2006, Pages: 509–519, Linda Ferrington, Eszter Kirilly, Douglas E. McBean, Henry J. Olverman, György Bagdy and Paul A. T. Kelly

    Version of Record online : 12 JUL 2006, DOI: 10.1111/j.1460-9568.2006.04923.x

  19. You have free access to this content
    The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) to rats

    British Journal of Pharmacology

    Volume 135, Issue 1, January 2002, Pages: 170–180, Annis O Mechan, Blanca Esteban, Esther O'Shea, J Martin Elliott, M Isabel Colado and A Richard Green

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0704442

  20. PRECLINICAL STUDY: Acquisition and reinstatement of MDMA-induced conditioned place preference in mice pre-treated with MDMA or cocaine during adolescence

    Addiction Biology

    Volume 14, Issue 4, October 2009, Pages: 447–456, Manuel Daza-Losada, Marta Rodríguez-Arias, María A. Aguilar and José Miñarro

    Version of Record online : 8 SEP 2009, DOI: 10.1111/j.1369-1600.2009.00173.x